Which hedge funds own MYGN? MYRIAD GENETICS INC, Q2 2026 13F holders
31 tracked hedge funds disclosed a position in MYGN (MYRIAD GENETICS INC) in their Q2 2026 13F filings, worth $166.2m in total. The largest holder by portfolio weight is PharVision Advisers, LLC at 1.8% of its book. 10 opened a new position this quarter: PharVision Advisers, LLC, Militia Capital Management LLC, Verdad Advisers, LP, Alpha Wealth Funds, LLC. 12 exited: Orbimed Advisors LLC, Glenview Capital Management, LLC, Gsa Capital Partners LLP.
- 31
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 10
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 12
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $6.6m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $157m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $166m
- Combined value Sum of the holders' reported positions in the security.
- 2.5%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Orbimed Advisors LLC | 2.7% | $123m |
| Glenview Capital Management, LLC | 0.7% | $24.4m |
| Gsa Capital Partners LLP | 0.10% | $1.5m |
| Y-Intercept (Hong Kong) Ltd | 0.06% | $2.9m |
| Scientech Research LLC | 0.05% | $55.7k |
| Oxford Asset Management LLP | 0.05% | $114k |
| Catalyst Funds Management Pty Ltd | 0.03% | $153k |
| Weiss Asset Management LP | 0.01% | $787k |
| Trexquant Investment LP | 0.01% | $1.8m |
| Laurion Capital Management LP | 0.01% | $65.0k |
| Renaissance Technologies LLC | 0.0% | $2.0m |
| Deerfield Management Company, L.P. | 0.0% | $2.3k |
Ownership over time
Who discovered MYGN first? Beta
The run: Q2 1999 → Q3 2000, ×19
| Tiger Global Management LLC | Q1 2014 | – | +0.2 pts |
| Glenview Capital Management, LLC | Q4 2020 | – | +0.2 pts |
| Oracle Investment Management Inc | Q2 2024 | – | +0.2 pts |
| Valiant Capital Management, L.P. | Q4 2014 | – | +0.1 pts |
| AMH Equity Ltd | Q2 2023 | – | 0.0 pts |
| Iridian Asset Management LLC | Q1 2014 | – | −0.1 pts |
| Scopia Capital Management LP high conviction | Q1 2014 | – | −0.6 pts |
| SG Capital Management LLC high conviction | Q1 2019 | – | −0.9 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.